bromodeoxyuridine has been researched along with ifosfamide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ernst, H; Fahrig, R; Fiedler, B; Heinrich, JC; Krupitza, G; Leisser, C; Nickel, B; Praha, C; Scherthan, H; Sonntag, D; Wilfert, F | 1 |
Braasch, K; Brüggemann, SK; Hagenah, W; Hinrichs, J; Kisro, J; Peters, SO; Radike, K; Wagner, T | 1 |
2 other study(ies) available for bromodeoxyuridine and ifosfamide
Article | Year |
---|---|
Inhibition of induced chemoresistance by cotreatment with (E)-5-(2-bromovinyl)-2'-deoxyuridine (RP101).
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Cisplatin; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Electrophoresis, Gel, Two-Dimensional; Fibroblasts; Ifosfamide; Methotrexate; Mice; Mitomycin; Mitoxantrone; NAD(P)H Dehydrogenase (Quinone); Rats; Rats, Sprague-Dawley; Sarcoma, Yoshida; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; STAT3 Transcription Factor; Trans-Activators; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2003 |
Chloroacetaldehyde: mode of antitumor action of the ifosfamide metabolite.
Topics: Acetaldehyde; Adenosine Triphosphate; Antineoplastic Agents, Alkylating; Bromodeoxyuridine; Cell Line, Tumor; Comet Assay; Cross-Linking Reagents; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Humans; Ifosfamide; Nucleic Acid Synthesis Inhibitors | 2006 |